Patents-Review.com
🔗 Permalink
Assignee profile:

AIM IMMUNOTECH INC.

City:

Ocala, Florida

Country:

United States

Published Applications:

14

Last publication date:

2024-11-14

Patent Grants:

5

Last grant date:

2025-05-27

Top Inventors for applications by AIM IMMUNOTECH INC.

These are the the leading inventors for applications assigned to AIM IMMUNOTECH INC.:

Recent patent applications by AIM IMMUNOTECH INC.

AIM IMMUNOTECH INC. based in Ocala, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-11-14
US20240376481A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR ENHANCING AND EXPANDING INFECTION INDUCED IMMUNITY

 #2 | 2024-10-24
US20240350527A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING POST-COVID CONDITIONS OF FATIGUE

 #3 | 2024-07-04
US20240218373A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING NEUROINFLAMMATION

 #4 | 2022-12-08 ✅ Patent 12,312,376 granted on 2025-05-27
US20220389050A1
Chemistry; metallurgy

Therapeutic double stranded RNA and methods for producing the same

 #5 | 2022-12-08 ✅ Patent 12,102,649 granted on 2024-10-01
US20220387475A1
Human necessities

Methods and compositions for treating endometriosis

 #6 | 2022-12-08
US20220387472A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #7 | 2022-12-01
US20220380769A1
Chemistry; metallurgy

METHODS, COMPOSITIONS, AND VACCINES FOR TREATING A VIRUS INFECTION

 #8 | 2022-11-10
US20220356476A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS USEFUL FOR EBOLA VIRUS INFECTION

 #9 | 2022-09-08
US20220280547A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING LONG COVID

 #10 | 2022-03-31
US20220096518A1
Human necessities

COMPOSITIONS AND METHODS FOR CANCER THERAPY

 #11 | 2022-03-03 ✅ Patent 11,813,281 granted on 2023-11-14
US20220062321A1
Human necessities

Methods for improving exercise tolerance in myalgic encephalomyelitis patients

 #12 | 2021-07-01
US20210196744A1
Human necessities

COMPOSITIONS FOR CANCER THERAPY AND METHODS

 #13 | 2020-06-25 ✅ Patent 11,813,279 granted on 2023-11-14
US20200197433A1
Human necessities

Compositions for cancer therapy and methods

 #14 | 2016-07-14 ✅ Patent 11,642,396 granted on 2023-05-09
US20160199449A1
Human necessities

Method of reducing antigenic drift or reassortment of viruses in a host animal using α interferon

Also check out AIM ImmunoTech Inc.'s (Ocala, United States) applicant profile with 8 patent applications submitted.

AssigneeID:

159841 ⎘